Global Genetic Disorders Drug Market Size, Share, Trends and Forecast 2020-2026

Description

This report focuses on Genetic Disorders Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Genetic Disorders Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Sanofi
Vertex
Takeda
Amgen
GW Pharmaceuticals
Pfizer
BioMarin
Sarepta

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Cystic Fibrosis (CF)
Duchenne Muscular Dystrophy (DMD)
Lysosomal Storage Disease (LSD)
Paroxysmal Nocturnal Hemoglobinuria (PNH)

Segment by Application
Clinic
Hospital

TABLE OF CONTENT

Table of Contents

1 Genetic Disorders Drug Market Overview
1.1 Product Overview and Scope of Genetic Disorders Drug
1.2 Genetic Disorders Drug Segment by Type
1.2.1 Global Genetic Disorders Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Cystic Fibrosis (CF)
1.2.3 Duchenne Muscular Dystrophy (DMD)
1.2.4 Lysosomal Storage Disease (LSD)
1.2.5 Paroxysmal Nocturnal Hemoglobinuria (PNH)
1.3 Genetic Disorders Drug Segment by Application
1.3.1 Genetic Disorders Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Clinic
1.3.3 Hospital
1.4 Global Genetic Disorders Drug Market Size Estimates and Forecasts
1.4.1 Global Genetic Disorders Drug Revenue 2015-2026
1.4.2 Global Genetic Disorders Drug Sales 2015-2026
1.4.3 Genetic Disorders Drug Market Size by Region: 2020 Versus 2026

2 Global Genetic Disorders Drug Market Competition by Manufacturers
2.1 Global Genetic Disorders Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Genetic Disorders Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Genetic Disorders Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Genetic Disorders Drug Manufacturing Sites, Area Served, Product Type
2.5 Genetic Disorders Drug Market Competitive Situation and Trends
2.5.1 Genetic Disorders Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Genetic Disorders Drug Players (Opinion Leaders)

3 Genetic Disorders Drug Retrospective Market Scenario by Region
3.1 Global Genetic Disorders Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Genetic Disorders Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Genetic Disorders Drug Market Facts & Figures by Country
3.3.1 North America Genetic Disorders Drug Sales by Country
3.3.2 North America Genetic Disorders Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Genetic Disorders Drug Market Facts & Figures by Country
3.4.1 Europe Genetic Disorders Drug Sales by Country
3.4.2 Europe Genetic Disorders Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Genetic Disorders Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Genetic Disorders Drug Sales by Region
3.5.2 Asia Pacific Genetic Disorders Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Genetic Disorders Drug Market Facts & Figures by Country
3.6.1 Latin America Genetic Disorders Drug Sales by Country
3.6.2 Latin America Genetic Disorders Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Genetic Disorders Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Genetic Disorders Drug Sales by Country
3.7.2 Middle East and Africa Genetic Disorders Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Genetic Disorders Drug Historic Market Analysis by Type
4.1 Global Genetic Disorders Drug Sales Market Share by Type (2015-2020)
4.2 Global Genetic Disorders Drug Revenue Market Share by Type (2015-2020)
4.3 Global Genetic Disorders Drug Price Market Share by Type (2015-2020)
4.4 Global Genetic Disorders Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Genetic Disorders Drug Historic Market Analysis by Application
5.1 Global Genetic Disorders Drug Sales Market Share by Application (2015-2020)
5.2 Global Genetic Disorders Drug Revenue Market Share by Application (2015-2020)
5.3 Global Genetic Disorders Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Genetic Disorders Drug Business
6.1 Sanofi
6.1.1 Corporation Information
6.1.2 Sanofi Description, Business Overview and Total Revenue
6.1.3 Sanofi Genetic Disorders Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi Products Offered
6.1.5 Sanofi Recent Development
6.2 Vertex
6.2.1 Vertex Genetic Disorders Drug Production Sites and Area Served
6.2.2 Vertex Description, Business Overview and Total Revenue
6.2.3 Vertex Genetic Disorders Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Vertex Products Offered
6.2.5 Vertex Recent Development
6.3 Takeda
6.3.1 Takeda Genetic Disorders Drug Production Sites and Area Served
6.3.2 Takeda Description, Business Overview and Total Revenue
6.3.3 Takeda Genetic Disorders Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Takeda Products Offered
6.3.5 Takeda Recent Development
6.4 Amgen
6.4.1 Amgen Genetic Disorders Drug Production Sites and Area Served
6.4.2 Amgen Description, Business Overview and Total Revenue
6.4.3 Amgen Genetic Disorders Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Amgen Products Offered
6.4.5 Amgen Recent Development
6.5 GW Pharmaceuticals
6.5.1 GW Pharmaceuticals Genetic Disorders Drug Production Sites and Area Served
6.5.2 GW Pharmaceuticals Description, Business Overview and Total Revenue
6.5.3 GW Pharmaceuticals Genetic Disorders Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 GW Pharmaceuticals Products Offered
6.5.5 GW Pharmaceuticals Recent Development
6.6 Pfizer
6.6.1 Pfizer Genetic Disorders Drug Production Sites and Area Served
6.6.2 Pfizer Description, Business Overview and Total Revenue
6.6.3 Pfizer Genetic Disorders Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Pfizer Products Offered
6.6.5 Pfizer Recent Development
6.7 BioMarin
6.6.1 BioMarin Genetic Disorders Drug Production Sites and Area Served
6.6.2 BioMarin Description, Business Overview and Total Revenue
6.6.3 BioMarin Genetic Disorders Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 BioMarin Products Offered
6.7.5 BioMarin Recent Development
6.8 Sarepta
6.8.1 Sarepta Genetic Disorders Drug Production Sites and Area Served
6.8.2 Sarepta Description, Business Overview and Total Revenue
6.8.3 Sarepta Genetic Disorders Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Sarepta Products Offered
6.8.5 Sarepta Recent Development

7 Genetic Disorders Drug Manufacturing Cost Analysis
7.1 Genetic Disorders Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Genetic Disorders Drug
7.4 Genetic Disorders Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Genetic Disorders Drug Distributors List
8.3 Genetic Disorders Drug Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Genetic Disorders Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Genetic Disorders Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Genetic Disorders Drug by Type (2021-2026)
10.2 Genetic Disorders Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Genetic Disorders Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Genetic Disorders Drug by Application (2021-2026)
10.3 Genetic Disorders Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Genetic Disorders Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Genetic Disorders Drug by Region (2021-2026)
10.4 North America Genetic Disorders Drug Estimates and Projections (2021-2026)
10.5 Europe Genetic Disorders Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Genetic Disorders Drug Estimates and Projections (2021-2026)
10.7 Latin America Genetic Disorders Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Genetic Disorders Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample